Pilot Study of Intrapartum Insulin Pump
NCT07420972
Autoimmune Diseases, Diabetes
View Trial DetailsNCT Number: NCT07615803
This study was a cross-sectional, observational design without involving random grouping or intervention. From July 2026 to June 2027, 199 children with type 1 diabetes who had received insulin treatment for at least 6 months and their main family caregivers were recruited by a continuous enrollment method from the endocrinology department of a tertiary children's hospital in Zhejiang Province. Qualified investigators conducted on-site distribution and collection of structured questionnaires, collecting general information of the children, the occurrence of skin complications, and the insulin injection behaviors of the caregivers. At the same time, personnel with ultrasound qualifications used a wireless handheld ultrasound combined with a skin lipid caliper to uniformly measure the subcutaneous fat thickness at 8 sites including the abdomen, buttocks, arms, and thighs.
Trial opening soon.
Get NotifiedAll sexes
Observational
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 2026.07-2027.06
The proportion of children with type 1 diabetes who are identified as having insulin injection-related lipohypertrophy. Lipohypertrophy will be determined as present if it is detected by physical examination and/or ultrasound assessment; results from these assessments will be combined into a single yes/no determination for each participant and reported as a proportion.
Contact information is provided by the study sponsor or research team.
The Children's Hospital of Zhejiang University School of Medicine
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07420972
Autoimmune Diseases, Diabetes
View Trial DetailsNCT07392853
Diabetes (Insulin-requiring, Type 1 or Type 2), Diabetes Mellitus
Budapest, Hungary
View Trial DetailsNCT07227805
Diabetes (Insulin-requiring, Type 1 or Type 2), Diabetes Mellitus
View Trial DetailsNCT07463209
Autoimmune Diseases, Diabetes (DM)
Chapel Hill, North Carolina, United States
View Trial Details